Isolation and characterization of antibody fragment selective for human Alzheimer's disease brain-derived tau variants.


Journal

Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437

Informations de publication

Date de publication:
10 2020
Historique:
received: 06 03 2019
revised: 23 03 2020
accepted: 15 04 2020
pubmed: 5 6 2020
medline: 30 6 2021
entrez: 5 6 2020
Statut: ppublish

Résumé

Reagents that can selectively recognize specific toxic tau variants associated with onset and progression of Alzheimer's disease (AD) and other tauopathies can be effective diagnostic and therapeutic tools. We utilized a novel atomic force microscopy-based biopanning protocol to isolate antibody fragments (single chain variable fragments, scFvs) that selectively bind tau variants present in human AD but not cognitively normal age-matched brain tissue. We identified 6 scFvs [Alzheimer's disease tau (ADT)-1 through 6] that readily distinguished between AD and control tissue and sera samples. We utilized 3 of the scFvs (ADT-2, ADT-4, and ADT-6) to analyze longitudinal plasma samples from 50 human patients, 25 patients which converted to AD during the study and 25 that remained cognitively normal. All 3 scFvs could distinguish the AD from control samples with higher tau levels in apolipoprotein E3/3 AD cases compared to apolipoprotein E3/4. Immunohistochemical analyses of human AD brain slices indicated several but not all tau variants overlapping with phosphorylated tau staining. Several reagents also showed therapeutic potential, protecting neuronal cells against AD tau-induced toxicity.

Identifiants

pubmed: 32497877
pii: S0197-4580(20)30134-2
doi: 10.1016/j.neurobiolaging.2020.04.014
pmc: PMC7484196
mid: NIHMS1600127
pii:
doi:

Substances chimiques

Biomarkers 0
Immunoglobulin Fragments 0
Single-Chain Antibodies 0
tau Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

7-14

Subventions

Organisme : NIA NIH HHS
ID : R01 AG054048
Pays : United States
Organisme : NIA NIH HHS
ID : R21 AG041472
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Références

Eur Neuropsychopharmacol. 2009 Oct;19(10):708-17
pubmed: 19423301
Nat Cell Biol. 2009 Jul;11(7):909-13
pubmed: 19503072
Proc Natl Acad Sci U S A. 1998 May 26;95(11):6157-62
pubmed: 9600934
Neurodegener Dis. 2008;5(3-4):143-5
pubmed: 18322373
J Neurosci. 2007 Apr 4;27(14):3650-62
pubmed: 17409229
J Alzheimers Dis. 2003 Apr;5(2):65-77
pubmed: 12719624
Acta Neuropathol Commun. 2017 Jun 7;5(1):41
pubmed: 28587664
J Alzheimers Dis. 2017;58(1):23-35
pubmed: 28372328
J Mol Biol. 2007 May 11;368(4):1132-44
pubmed: 17391701
Neurology. 1992 Mar;42(3 Pt 1):631-9
pubmed: 1549228
Neurosci Lett. 1993 Nov 12;162(1-2):179-82
pubmed: 8121624
Science. 2005 Jul 15;309(5733):476-81
pubmed: 16020737
Arch Neurol. 2003 May;60(5):729-36
pubmed: 12756137
J Biol Chem. 2009 May 8;284(19):12845-52
pubmed: 19282288
Neuropathology. 2015 Aug;35(4):354-89
pubmed: 25619230
J Vis Exp. 2015 Feb 12;(96):
pubmed: 25742170
Neurochem Int. 2011 Mar;58(4):458-71
pubmed: 21215781
Curr Alzheimer Res. 2008 Dec;5(6):591-8
pubmed: 19075586
J Neurochem. 2010 Mar;112(6):1353-67
pubmed: 19943854
Arch Neurol. 2004 Jan;61(1):59-66
pubmed: 14732621
J Neurosci. 2008 Jan 16;28(3):737-48
pubmed: 18199773
Biotechnol Prog. 2013 Mar-Apr;29(2):463-71
pubmed: 23359572
Ann Neurol. 2009 Apr;65(4):403-13
pubmed: 19296504
Neurosci Res. 2006 Mar;54(3):197-201
pubmed: 16406150
Prog Neurobiol. 2008 Jun;85(2):148-75
pubmed: 18448228
Nat Rev Neurosci. 2007 Sep;8(9):663-72
pubmed: 17684513
Mol Neurodegener. 2008 Jul 10;3:8
pubmed: 18616804
Radiology. 1982 Apr;143(1):29-36
pubmed: 7063747
J Alzheimers Dis. 2008 Aug;14(4):393-9
pubmed: 18688089
Exp Neurol. 2002 Oct;177(2):475-93
pubmed: 12429193
J Neurosci. 2010 Sep 8;30(36):11938-50
pubmed: 20826658
Proc Natl Acad Sci U S A. 2011 Apr 5;108(14):5819-24
pubmed: 21421841
Neurobiol Aging. 2004 Jul;25(6):697-711
pubmed: 15165691
J Neurochem. 1993 Nov;61(5):1828-34
pubmed: 8228996
Cell Motil Cytoskeleton. 2008 Feb;65(2):89-99
pubmed: 18000878
Science. 2007 May 4;316(5825):750-4
pubmed: 17478722
J Neurosci. 2007 Sep 12;27(37):9916-27
pubmed: 17855606
J Neurosci. 2009 Aug 26;29(34):10741-9
pubmed: 19710325
Neuron. 2007 Feb 1;53(3):337-51
pubmed: 17270732
Nat Rev Neurosci. 2011 Feb;12(2):65-72
pubmed: 21193853
J Neurochem. 2003 Aug;86(3):582-90
pubmed: 12859672
Science. 2007 Jun 8;316(5830):1416-7
pubmed: 17556561

Auteurs

Lalitha Venkataraman (L)

Department of Neuroscience, School of Life Sciences, Arizona State University, Tempe, AZ, USA.

Ping He (P)

Department of Chemical Engineering, School for Engineering, Matter, Transport and Energy, Arizona State University, Tempe, AZ, USA.

Philip Schulz (P)

Department of Chemical Engineering, School for Engineering, Matter, Transport and Energy, Arizona State University, Tempe, AZ, USA.

Michael R Sierks (MR)

Department of Chemical Engineering, School for Engineering, Matter, Transport and Energy, Arizona State University, Tempe, AZ, USA. Electronic address: sierks@asu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH